Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10226
CALL
Oceaneering
OII
$5.2B
| $154K | ﹤0.01% |
6,500
-19,000
| -75% | -$439K |
|
10227
Brown-Forman Class A
BF.A
$13.3B
| $153K | ﹤0.01% |
3,476
-2,034
| -37% | -$97K |
|
10228
CALL
Littelfuse
LFUS
$11.6B
| $153K | ﹤0.01% |
600
-1,800
| -75% | -$446K |
|
10229
Ramaco Resources Class B
METCB
$432M
| $153K | ﹤0.01% |
+15,225
| New | +$159K |
|
10230
CALL
Fidelity MSCI Materials Index ETF
FMAT
$614M
| $153K | ﹤0.01% |
+3,100
| New | +$158K |
|
10231
PUT
iShares MSCI Spain ETF
EWP
$2.22B
| $153K | ﹤0.01% |
4,900
-11,900
| -71% | -$383K |
|
10232
CALL
Glacier Bancorp
GBCI
$6.5B
| $153K | ﹤0.01% |
4,100
-1,100
| -21% | -$40.9K |
|
10233
Performance Shipping
PSHG
$21.9M
| $153K | ﹤0.01% |
+70,807
| New | +$153K |
|
10234
PUT
SunCoke Energy
SXC
$794M
| $153K | ﹤0.01% |
15,600
-5,300
| -25% | -$54.8K |
|
10235
PUT
PetMed Express
PETS
$38.9M
| $153K | ﹤0.01% |
37,700
-18,200
| -33% | -$77.7K |
|
|
MRNO
10236
Murano Global Investments
MRNO
$18.6M
| $153K | ﹤0.01% |
+15,971
| New | +$162K |
|
10237
CALL
Stoke Therapeutics
STOK
$2.02B
| $153K | ﹤0.01% |
11,300
-38,500
| -77% | -$520K |
|
|
ODP
10238
DELISTED
ODP
ODP
| $153K | ﹤0.01% |
+3,886
| New | +$173K |
|
10239
Mineralys Therapeutics
MLYS
$2.27B
| $152K | ﹤0.01% |
13,034
+12,937
| +13,337% | +$163K |
|
|
VTYX
10240
PUT
DELISTED
Ventyx Biosciences
VTYX
| $152K | ﹤0.01% |
66,000
+19,200
| +41% | +$79.8K |
|
|
CDMO
10241
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $152K | ﹤0.01% |
21,300
-29,200
| -58% | -$223K |
|
10242
CALL
Metallus
MTUS
$904M
| $152K | ﹤0.01% |
7,500
-1,200
| -14% | -$26.3K |
|
10243
CALL
Franklin Covey
FC
$229M
| $152K | ﹤0.01% |
4,000
+3,100
| +344% | +$116K |
|
10244
PUT
Baytex Energy
BTE
$3.06B
| $152K | ﹤0.01% |
43,600
-5,000
| -10% | -$17.9K |
|
10245
Kamada
KMDA
$437M
| $152K | ﹤0.01% |
30,304
+1,549
| +5% | +$8.17K |
|
10246
PUT
Clarus
CLAR
$140M
| $151K | ﹤0.01% |
22,500
-17,700
| -44% | -$117K |
|
10247
CALL
Banco Santander
SAN
$211B
| $151K | ﹤0.01% |
32,700
+10,900
| +50% | +$53.7K |
|
|
RVNC
10248
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $151K | ﹤0.01% |
58,900
-39,800
| -40% | -$136K |
|
10249
CALL
Artivion
AORT
$1.42B
| $151K | ﹤0.01% |
5,900
-12,100
| -67% | -$271K |
|
10250
BGSF Inc
BGSF
$60.4M
| $151K | ﹤0.01% |
+17,694
| New | +$143K |
|
Similar funds
Citadel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.
- Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
- Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.